Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-06-12	0.000300 $	0.00%	4,209,375
26-06-11	0.000300 $	0.00%	630,000
26-06-10	0.000300 $	0.00%	2,932,336
26-06-09	0.000300 $	-25.00%	313,502
26-06-08	0.000400 $	0.00%	4,569,343

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Delayed OTC Markets Other stock markets 11:47:36 2026-06-12 EDT			5-day change	1st Jan Change
0.000300 ^USD	0.00%		-25.00%	-40.00%

04-16	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026	CI
02-19	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025	CI

Market Cap	2.35M 2.03M 1.87M 1.75M 3.27M 223M 3.33M 22.04M 8.59M 109M 8.8M 8.61M 376M	P/E Ratio 2024	-9.52x	P/E Ratio 2025	-11.8x
Enterprise Value	3.35M 2.89M 2.66M 2.49M 4.67M 318M 4.74M 31.44M 12.26M 155M 12.56M 12.29M 536M	EV / Sales 2024	28.9x	EV / Sales 2025	25.6x
Free-Float	41.59%	Yield 2024 *	-	Yield 2025	-

04-16	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026	CI
02-19	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025	CI
25-10-22	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025	CI
25-10-06	Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors	CI
25-09-22	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025	CI
25-09-21	Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
25-04-22	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025	CI
25-01-21	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024	CI
25-01-06	Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products	CI
24-12-26	Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding	CI
24-11-26	Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024	CI
24-11-25	Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip	CI
24-10-21	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2024	CI

06-08	CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers	NE
06-01	CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation	NE
02-19	Cannabis Bioscience International : Quarterly Report for Quarter Ending November 30, 2025 (Form 10-Q)	PU
01-21	CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio	NE
01-12	CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence	NE

Cannabis Bioscience International Holdings, Inc. Stock

Stocks

CBIH

US16948K1060

Biotechnology & Medical Research

Valuation: Cannabis Bioscience International Holdings, Inc.

Chart: Cannabis Bioscience International Holdings, Inc.

Latest news : Cannabis Bioscience International Holdings, Inc.

Press Releases: Cannabis Bioscience International Holdings, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Cannabis Bioscience International Holdings, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	-25.00%
Current month	+50.00%
1 month	+50.00%
3 months	-25.00%
6 months	-57.14%
Current year	-40.00%

Manager	Title	Age	Since
Dante Picazo CEO	Chief Executive Officer	70	2019-12-18
John Jones TRE	Treasurer	61	2024-05-05
Jose Torres SEC	Corporate Secretary	66	2019-12-18

Director	Title	Age	Since
Dante Picazo BRD	Director/Board Member	70	2019-12-18
Jose Torres BRD	Director/Board Member	66	2019-12-18
John Jones BRD	Director/Board Member	61	2024-05-05

	2024	2025
Net sales	249K 215K 198K 185K 347K 23.65M 353K 2.34M 912K 11.51M 934K 914K 39.86M	303K 262K 241K 226K 423K 28.8M 430K 2.85M 1.11M 14.02M 1.14M 1.11M 48.54M
Net income	-651K -563K -518K -485K -909K -61.91M -923K -6.12M -2.39M -30.13M -2.44M -2.39M -104M	-549K -474K -437K -409K -766K -52.17M -778K -5.16M -2.01M -25.39M -2.06M -2.02M -87.92M
Net Debt	939K 811K 748K 700K 1.31M 89.28M 1.33M 8.83M 3.44M 43.46M 3.53M 3.45M 150M	1M 864K 796K 745K 1.4M 95.09M 1.42M 9.4M 3.67M 46.28M 3.75M 3.67M 160M

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.01
10 years	0		0.27

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.	0.00%	-25.00%	-50.00%	-40.00%	3.52M
LONZA GROUP AG	-0.35%	+0.97%	-15.96%	-12.73%	42.96B
REVOLUTION MEDICINES, INC.	+3.54%	+3.33%	+275.09%	+509.25%	31.73B
IQVIA HOLDINGS INC.	-1.06%	-2.31%	+12.62%	-15.42%	30.22B
BEONE MEDICINES AG	+1.71%	-1.93%	-4.21%	+24.25%	28.94B
CELLTRION, INC.	+4.09%	-1.98%	+11.99%	+17.37%	23.87B
MEDPACE HOLDINGS, INC.	-0.76%	+3.72%	+54.99%	+116.11%	13.57B
EUROFINS SCIENTIFIC SE	-0.40%	-1.29%	+6.06%	+7.59%	12.96B
ASCENDIS PHARMA A/S	+2.53%	+5.02%	-	-	13.39B
IONIS PHARMACEUTICALS, INC.	-0.86%	-1.75%	+105.45%	+75.79%	12.2B
Average	+0.84%	-3.14%	+44.00%	+75.80%	20.98B
Weighted average by Cap.	+1.04%	-1.08%	+54.46%	+96.00%